Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in …
…, AI Tukhvatulin, OV Zubkova, AS Dzharullaeva… - The Lancet, 2021 - thelancet.com
Background A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac
(Sputnik V), showed a good safety profile and induced strong humoral and cellular immune …
(Sputnik V), showed a good safety profile and induced strong humoral and cellular immune …
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1 …
…, AI Tukhvatulin, DV Shcheblyakov, AS Dzharullaeva… - The Lancet, 2020 - thelancet.com
Background We developed a heterologous COVID-19 vaccine consisting of two components,
a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (…
a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (…
[HTML][HTML] An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus …
…, OV Zubkova, AS Dzharullaeva… - The Lancet Regional …, 2021 - thelancet.com
Background While the world is experiencing another wave of COVID-19 pandemic, global
vaccination program is hampered by an evident shortage in the supply of licensed vaccines. …
vaccination program is hampered by an evident shortage in the supply of licensed vaccines. …
[HTML][HTML] Powerful complex immunoadjuvant based on synergistic effect of combined TLR4 and NOD2 activation significantly enhances magnitude of humoral and …
AI Tukhvatulin, AS Dzharullaeva, NM Tukhvatulina… - PLoS …, 2016 - journals.plos.org
Binding of pattern recognition receptors (PRRs) by pathogen-associated molecular patterns
(PAMPs) activates innate immune responses and contributes to development of adaptive …
(PAMPs) activates innate immune responses and contributes to development of adaptive …
Receptor Mincle promotes skin allergies and is capable of recognizing cholesterol sulfate
…, AI Tukhvatulin, AS Dzharullaeva… - Proceedings of the …, 2017 - National Acad Sciences
Sterile (noninfected) inflammation underlies the pathogenesis of many widespread diseases,
such as allergies and autoimmune diseases. The evolutionarily conserved innate immune …
such as allergies and autoimmune diseases. The evolutionarily conserved innate immune …
Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates
…, IV Dolzhikova, AS Dzharullaeva… - Emerging Microbes & …, 2022 - Taylor & Francis
Although unprecedented efforts aiming to stop the COVID-19 pandemic have been made
over the past two years, SARSCoV-2 virus still continues to cause intolerable health and …
over the past two years, SARSCoV-2 virus still continues to cause intolerable health and …
Sputnik Light booster after Sputnik V vaccination induces robust neutralizing antibody response to B. 1.1. 529 (Omicron) SARS-CoV-2 variant
…, NA Kuznetsova, MM Megeryan, AS Dzharullaeva… - medRxiv, 2021 - medrxiv.org
COVID-19 vaccination campaign has been launched around the world. More than 8 billion
vaccines doses have been administered, according to the WHO. Published studies shows …
vaccines doses have been administered, according to the WHO. Published studies shows …
[HTML][HTML] Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A
…, EN Bykonia, EP Mazunina, AS Dzharullaeva… - Frontiers in …, 2023 - frontiersin.org
Single-domain antibodies (sdAbs, VHHs, or nanobodies) are a promising tool for the treatment
of both infectious and somatic diseases. Their small size greatly simplifies any genetic …
of both infectious and somatic diseases. Their small size greatly simplifies any genetic …
[HTML][HTML] Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an …
…, IV Dolzhikova, AS Dzharullaeva… - Frontiers in …, 2023 - frontiersin.org
To protect young individuals against SARS-CoV-2 infection, we conducted an open-label,
prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the …
prospective, non-randomised dose-escalation Phase 1/2 clinical trial to evaluate the …
Stimulation of Dectin‐1 and Dectin‐2 during parenteral immunization, but not Mincle, induces secretory IgA in intestinal mucosa
AS Dzharullaeva, AI Tukhvatulin… - Journal of …, 2018 - Wiley Online Library
Induction of a robust and long‐lived mucosal immune response during vaccination is critical
to achieve protection against numerous pathogens. However, traditional injected vaccines …
to achieve protection against numerous pathogens. However, traditional injected vaccines …
